Good Fellow Healthcare Holdings Limited

As of September 30, 2023, Good Fellow Healthcare Holdings Limited carries a market capitalization of 746.84M, placing it among publicly traded companies globally. Its enterprise value stands at 743.60M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of September 30, 2023, Good Fellow Healthcare Holdings Limited has 727.55M shares outstanding.

These figures are as of September 30, 2023. The price-to-sales ratio is 10.69, and the price-to-book ratio stands at 53.06.

These figures are as of September 30, 2023. The EV/Sales ratio of 14.01 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 743.60M versus a market cap of 746.84M, with the gap driven by net debt and cash on the balance sheet.

As of September 30, 2023, Good Fellow Healthcare Holdings Limited maintains a current ratio of 0.45, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 45.42, indicating elevated leverage, while an interest coverage ratio of -18.95 demonstrates limited ability to service its debt obligations.

Over the twelve months ended September 30, 2023, Good Fellow Healthcare Holdings Limited posted a negative return on equity (ROE) of -35.37, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -14.39, reflecting losses generated across the asset base. The company generates approximately 383,234.66 in revenue per employee across its workforce of 138.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 11.40 indicates how many times Good Fellow Healthcare Holdings Limited sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended September 30, 2023, Good Fellow Healthcare Holdings Limited recorded an income tax benefit of -174,000.00 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -6.26M and -6.33M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Good Fellow Healthcare Holdings Limited's stock has declined approximately 68.64% over the past 52 weeks. The 50-day moving average sits at 0.33, while the 200-day moving average is 0.63.

Over the twelve months ended September 30, 2023, Good Fellow Healthcare Holdings Limited generated 53.08M in revenue and converted that into -6.33M in net income, yielding earnings per share of -0.01. EBITDA reached -5.95M, while operating income came in at -9.93M.

As of September 30, 2023, Good Fellow Healthcare Holdings Limited holds 5.39M in cash and equivalents against 5.07M in total debt, resulting in a net debt position of -2.98M. Total book value stands at 14.08M, with working capital of -10.67M providing operational flexibility.

Over the twelve months ended September 30, 2023, Good Fellow Healthcare Holdings Limited posted a gross margin of 43.68, reflecting its pricing power and cost economics. The operating margin of -18.70 and net profit margin of -11.93 provide insight into operational efficiency.

Good Fellow Healthcare Holdings Limited's most recent stock split took place on September 22, 2026 with a 5:1 split ratio.

As of September 30, 2023, Good Fellow Healthcare Holdings Limited has an Altman Z-Score of -9.44, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.